Fred Hutchinson Cancer Research Center donations received

This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of December 2019. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.

Table of contents

Basic donee information

ItemValue
Country
Facebook page HutchinsonCenter
Websitehttps://www.fredhutch.org/en/news/fred-hutch-south-africa.html
Twitter usernamefredhutch
Wikipedia pagehttps://en.wikipedia.org/wiki/Fred_Hutchinson_Cancer_Research_Center
Instagram usernameFredHutch

Donation amounts by donor and year for donee Fred Hutchinson Cancer Research Center

Donor Total 2017 2016 2015 2014 2013 2012 2011 2009 2008 2007 2006 1989 1986
Bill and Melinda Gates Foundation (filter this donee) 232,355,833.32 31,571,506.00 90,343,238.00 2,609,460.00 33,388,590.00 11,833,777.00 8,998,330.00 1,157,694.00 100,000.00 100,000.00 12,279,298.00 39,973,940.32 0.00 0.00
MacArthur Foundation (filter this donee) 50,000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 25,000.00 25,000.00
Total 232,405,833.32 31,571,506.00 90,343,238.00 2,609,460.00 33,388,590.00 11,833,777.00 8,998,330.00 1,157,694.00 100,000.00 100,000.00 12,279,298.00 39,973,940.32 25,000.00 25,000.00

Full list of donations in reverse chronological order (39 donations)

DonorAmount (current USD)Donation dateCause areaURLInfluencerNotes
Bill and Melinda Gates Foundation49,815.002017-09-07Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to develop methods and computational tools in biostatistics, computational biology, and mathematical modeling that will improve the quantitative science insightfulness and rigor of the HVTN 701 and 702 trial design and analysis for assessing immune correl; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation-148,490.002017-08-04Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to optimize and augment methods to identify mucosal immune factors that may contribute to HIV prevention and vaccine-induced protection.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-287,488.002017-08-04Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to provide general operating support for vaccine immunology statistical center and related projects; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-1,525,562.002017-07-06Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to provide statistical support to generate novel analytic methods and tools, and clinical and pre-clinical trial design and analysis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-320,101.002017-07-06Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to provide general operating support associated with the Vaccine Statistical Support platform; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation34,895,488.002017-06-30Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to support a test of concept efficacy trial to determine if a novel experimental HIV vaccine prevents HIV infection in women in southern Africa who are at high risk for HIV infection.; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation-1,092,156.002017-03-10Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to establish a vaccine immunology statistical center that will provide statistical and data management support to the Vaccine Discovery Centers; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,576,338.002016-12-16Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to support the development and clinical evaluation of an HIV vaccine regimen, in the region of the globe most heavily burdened by the HIV epidemic, specifically clade C epidemic in Southern Africa; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation-2,595,322.002016-12-07Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to carry out experimental studies in humans to determine if and how novel adjuvant and HIV-1 envelope immunogen combinations can induce higher levels, longer lasting, and qualitatively improved HIV-1 antibodies that may protect against HIV-1 acquisition; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation6,745,804.002016-10-28Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to provide statistical support to generate novel analytic methods and tools, and clinical and pre-clinical trial design and analysis; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,884,633.002016-10-20Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to provide general operating support associated with the Vaccine Statistical Support platform; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation3,911,293.002016-08-26Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to provide assistance in study design, assay development, data interpretation, and a data sharing portal to foundation grantees working to design candidate HIV vaccines and evaluate those vaccines in laboratory studies and clinical trials; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation15,144,268.002016-08-12Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to provide statistical support and a data sharing portal to foundation grantees working to design candidate HIV vaccines and evaluate those vaccines in laboratory studies and clinical trials; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation63,676,224.002016-07-26Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to support an efficacy trial of a candidate HIV vaccine in the Republic of South Africa to determine if this vaccine can improve upon the modest efficacy results obtained with a similar vaccine in the “RV144” trial conducted in Thailand.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation2,609,460.002015-04-03Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to establish a vaccine immunology statistical center that will provide statistical and data management support to the Vaccine Discovery Centers; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation16,175,191.002014-11-21Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to support the expeditious discovery of HIV vaccines with increased global relevance, effectiveness, efficiency, and accessibility; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation7,336,185.002014-11-17Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to carry out experimental studies in humans to determine if and how novel adjuvant and HIV-1 envelope immunogen combinations can induce higher levels, longer lasting, and qualitatively improved HIV-1 antibodies that may protect against HIV-1 acquisition; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation4,802,089.002014-11-07Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to support the development and clinical evaluation of an HIV vaccine regimen, in the region of the globe most heavily burdened by the HIV epidemic, specifically clade C epidemic in Southern Africa; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation938,885.002014-11-04Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to provide general operating support for vaccine immunology statistical center and related projects; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-474,566.002014-10-28Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to establish a vaccine immunology statistical center that will provide statistical and data management support to the Vaccine Discovery Centers; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation474,566.002014-10-28Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to facilitate and speed the development and licensure of a safe, effective prophylactic HIV-1 vaccine that can be globally deployed to halt the HIV-1 pandemic; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation3,084,907.002014-08-15Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to establish a vaccine immunology statistical center that will provide statistical and data management support to the Vaccine Discovery Centers; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,051,333.002014-08-01Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to develop methods and computational tools in biostatistics, computational biology, and mathematical modeling that will improve the quantitative science insightfulness and rigor of the HVTN 701 and 702 trial design and analysis for assessing immune correl; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation7,146,511.002013-11-07Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to increase capacity to conduct HIV vaccine clinical trials, including licensure trials, in highly impacted populations in clade C region of southern Africa.; Aid type: Other technical assistance. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation2,989,361.002013-11-06Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to optimize and augment methods to identify mucosal immune factors that may contribute to HIV prevention and vaccine-induced protection.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation700.002013-09-19Global health/Health policy and administrative managementhttps://iatiregistry.org/publisher/bmgf-- for general operating support. 2013 Obliteride. Investment start date: 9/19/2013 to end date: 10/3/2013. Grantee name: Fred Hutchinson Cancer Research Center; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected countries: United states of america (the).
Bill and Melinda Gates Foundation1,697,205.002013-07-01Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to facilitate and speed the development and licensure of a safe, effective prophylactic HIV-1 vaccine that can be globally deployed to halt the HIV-1 pandemic; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation998,330.002012-11-02Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to establish a vaccine immunology statistical center that will provide statistical and data management support to the Vaccine Discovery Centers; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation8,000,000.002012-02-21Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to establish a vaccine immunology statistical center that will provide statistical and data management support to the Vaccine Discovery Centers; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,157,694.002011-10-17Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to facilitate and speed the development and licensure of a safe, effective prophylactic HIV-1 vaccine that can be globally deployed to halt the HIV-1 pandemic; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation100,000.002009-02-26Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to identify inhibitors of a bacterial DNA repair enzyme that allows tuberculosis to mutate. Identifying these inhibitors could lead to therapies that kill bacteria and limit drug resistance.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation100,000.002008-09-12Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to develop a library of media compounds needed to optimize in vitro production of infective malaria sporozites needed for use in an effective vaccine; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation11,879,298.002007-07-06Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to elucidate the innate and adaptive immune responses that can protect against HIV-1 infection at all ages; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation400,000.002007-03-13Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to convene the annual AIDS Vaccine 2007 International Conference. AIDS Vaccine Conference 2007. Investment start date: 12/1/2006 to end date: 12/1/2007. Grantee name: Fred Hutchinson Cancer Research Center; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-44,455.682006-11-27Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to convene the annual AIDS Vaccine 2007 International Conference. AIDS Vaccine Conference 2007. Investment start date: 12/1/2006 to end date: 12/1/2007. Grantee name: Fred Hutchinson Cancer Research Center; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation9,945,896.002006-06-19Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to establish a Vaccine Immunology Statistical Center (VISC) to provide statistical and data management support to the Vaccine Discovery Centers; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation30,072,500.002006-06-16Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to improve HIV vaccines that can control the AIDS epidemic. Harnessing Innate Immunity to Enhance the Immunogenicity of T-Cell Inducing HIV Vaccines. Investment start date: 8/1/2006 to end date: 7/31/2013. Grantee name: Fred Hutchinson Cancer Research Cen; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
MacArthur Foundation25,000.001989FIXMEhttps://www.macfound.org/grants/-- To support a research project on molecular biology of parasitic diseases. Affected countries: United States; affected states: Washington; affected cities: Seattle.
MacArthur Foundation25,000.001986FIXMEhttps://www.macfound.org/grants/-- To support research on the role of scavenged host glycolipids in the autoimmune neuropathology of Chagas disease. Affected countries: United States; affected states: Washington; affected cities: Seattle.